<乌鸦传媒>FDA Warns Mercola for Selling Bogus COVID Treatments Controversial physician in trouble for claims about vitamin C, vitamin D, and quercetin products Mar 05, 2021
<乌鸦传媒>J&J COVID Vaccine Gets Green Light from FDA Panel No dissent on question of whether benefits outweigh risks Feb 26, 2021
<乌鸦传媒>Device to Prevent Athletes' Brain Injury Wins FDA Nod Low-tech neck collar keeps brain from "sloshing" during moderate impacts Feb 26, 2021
<乌鸦传媒>FDA Advisors Pan Drug-Coated Balloon for Lower-Leg Ischemia Panel members cite muddy efficacy data Feb 18, 2021
<乌鸦传媒>First Drug Approved for Some HFpEF FDA doesn't set hard limits on ejection fraction in expanded indication Feb 16, 2021
<乌鸦传媒>New Drug OK'd for Chemo-Induced Myelosuppression in SCLC CDK4/6 inhibitor cut the risk for severe neutropenia in small-cell lung cancer patients Feb 13, 2021
<乌鸦传媒>First Immunotherapy Approved for Basal Cell Carcinoma Objective responses in 27% of previously treated patients who received cemiplimab Feb 10, 2021
<乌鸦传媒>FDA Panel Slows the Roll for Pembrolizumab in Breast Cancer Advisory committee: Wait for more data before considering neoadjuvant indication Feb 09, 2021
<乌鸦传媒>Has Pembrolizumab Finally Met an Indication FDA Doesn't Like? Agency staff skeptical of data in early breast cancer Feb 08, 2021
<乌鸦传媒>HCP Busted for Selling Fake Stem Cell Therapy Assistant physician and Missouri state legislator indicted for wire fraud, other crimes Feb 04, 2021
<乌鸦传媒>Combined Cath Approach No Match for Surgery for Aortic Stenosis, CAD Pacemakers increasingly an issue in TAVR plus PCI Jan 30, 2021
<乌鸦传媒>Will Recovering COVID-19 Patients Soon Be Walking Around on ECMO? This year's winner of the STS "Shark Tank" session Jan 30, 2021
<乌鸦传媒>JAK Inhibitor Misses Endpoint in Safety Study. Now What? Major blow to popular class of oral rheumatology drugs Jan 27, 2021
<乌鸦传媒>Cancer and COVID; Booze and Cancer; 'Screech' Starts Chemo News, features, and commentary about cancer-related issues Jan 21, 2021
<乌鸦传媒>Feds Crack Down on Vitamin D COVID 'Cures' Georgia-based companies ordered to stop sales after national recall, DOJ says Jan 11, 2021
<乌鸦传媒>Promising Peanut Allergy Treatments Hit Snags in 2020 COVID-19 interrupts Palforzia rollout; FDA slams door on competitor's patch therapy Jan 03, 2021
<乌鸦传媒>Metformin Recalls Ballooned in 2020 Last addition to the list in November brought number to 254 products recalled Dec 29, 2020
<乌鸦传媒>How Do We Inject Confidence Into Vaccine Hesitant Americans? "We need to really up our game in terms of communicating," says Peter Hotez, MD, PhD Dec 23, 2020 podcast
<乌鸦传媒>LVAD Approved for Children FDA clears the way for HeartMate 3 use in younger population Dec 18, 2020
<乌鸦传媒>'We Want Them Infected'; Extra Vax Doses; Tom Cruise, Distancing Enforcer A daily roundup of news on COVID-19 and the rest of medicine Dec 17, 2020
<乌鸦传媒>FDA Panel Backs Entresto, Spironolactone for Broader HF Use But committee stops short of advocating categorical approval for HFpEF Dec 16, 2020
<乌鸦传媒>FDA OK's First-Ever Synthetic Implant for ACL Tears Bioresorbable device fills gap between torn ligament ends Dec 16, 2020
<乌鸦传媒>FDA Review Gives Rosy Outlook for What Could Be First HFpEF Drugs Advisory committee weigh unusual moves for Entresto and spironolactone Dec 14, 2020
<乌鸦传媒>Saxenda OK'd for Teens with Obesity Liraglutide label now includes adolescents as young as 12 Dec 07, 2020
<乌鸦传媒>FDA OKs 'Game Changer' Radiotracer for Prostate Cancer PET imaging drug detected metastasis at initial diagnosis, outperformed standard for PSA recurrence Dec 01, 2020
<乌鸦传媒>Colchicine Approval Took a Huge Toll on CMS As centuries-old drug is explored for COVID-19, study details the price of approval Nov 30, 2020
<乌鸦传媒>FDA OKs JAK Inhibitor and Remdesivir Combo for Severe COVID-19 EUA first for drug that acts on inflammation pathway, agency says Nov 19, 2020
<乌鸦传媒>Omega-3s Humbled by Corn Oil Placebo in Two Trials Implications for REDUCE-IT's icosapent ethyl unclear Nov 15, 2020
<乌鸦传媒>Omecamtiv's Benefit in HFrEF Trial Gets Lukewarm Reception Can novel oral drug stand out from the crowd? Nov 13, 2020
<乌鸦传媒>Doc Convicted for Needless Surgeries; COVID Test Racket; Biden's FDA Chief The past week in healthcare investigations Nov 11, 2020
<乌鸦传媒>Presbyopia Device Fails to Win Over FDA Panel Data suggest modest benefit and risk for scleral implant system Nov 10, 2020
<乌鸦传媒>Brilinta Wins Indication in Recurrent Stroke Prevention FDA approval based on THALES give the drug a foothold beyond CVD Nov 06, 2020
<乌鸦传媒>FDA Warns Against NSAIDs in Pregnancy After 20 Weeks Risk of kidney complications and low amniotic fluids may jeopardize fetus Oct 15, 2020
<乌鸦传媒>Reddit Users Self-Medicating With CBD for Treatable Conditions Patients may be substituting cannabis compound for evidence-based care Oct 15, 2020
<乌鸦传媒>FDA Panel: Some Risk OK for Olanzapine Combo With Less Weight Gain 11-6 majority said labeling was sufficient to mitigate dangers from opioid antagonist component Oct 09, 2020
<乌鸦传媒>FDA Panel: All Thumbs Down for Amphetamine Product Meant to Deter Abuse Unanimous vote that risks outweigh benefits Oct 09, 2020
<乌鸦传媒>Teen's Death Prompts Warning on 'Benadryl Challenge' FDA tries to squelch latest stupid craze Sep 25, 2020
<乌鸦传媒>How Accurate Are Home Blood Oxygen Monitors? The Skeptical Cardiologist examines pulse oximeters labeled not for medical use Sep 17, 2020
<乌鸦传媒>A Closer Look at FDA Decision to Pull Lorcaserin More cancers, multiple primaries, and deaths in CAMELLIA-TIMI 61 influenced agency decision Sep 09, 2020
<乌鸦传媒>Did Reformulated OxyContin Really Discourage Abuse? FDA advisors to review Purdue Pharma's flagship product, redesigned in 2010 to resist snorting and injection Sep 09, 2020
